• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿曼苏丹国布赖米医院新冠肺炎患者病毒载量与生化和血液学指标的相关性:一项横断面研究

Correlation of Viral Load With the Biochemical and Hematological Profiles of COVID-19 Patients in Al Buraimi Hospital, Sultanate of Oman: A Cross-Sectional Study.

作者信息

Al Badi Eida, Al Shukri Intisar, Al Mahruqi Samira

机构信息

Microbiology, Al Buraimi Hospital, Al Buraimi, OMN.

Virology, Central Public Health Laboratory, Directorate General for Disease Surveillance and Control, Muscat, OMN.

出版信息

Cureus. 2023 Feb 20;15(2):e35228. doi: 10.7759/cureus.35228. eCollection 2023 Feb.

DOI:10.7759/cureus.35228
PMID:36968904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10032618/
Abstract

Background Rapid identification of COVID-19 is crucial during the pandemic for the treatment and management of patients. Thus, early diagnosis of the disease using laboratory parameters can help in the rapid management of infected patients. This study aimed to investigate the correlation of viral load with hematological and biochemical parameters. This will ultimately help physicians to better understand the dynamics of this novel virus and aid in the management of patients. Methodology Laboratory confirmation of SARS-CoV-2 was performed by reverse transcription-polymerase chain reaction (RT-PCR) at the Al-Buraimi Hospital Laboratory Department using oropharyngeal and nasopharyngeal swabs. Positive cases were collected from July 2020 to January 2021 to be enrolled in this study. Results In this study, 264 confirmed positive patients were included initially and divided into three groups according to their cycle threshold (Ct) values obtained by PCR. Out of the total 264 patients, 174 (65.9%) were male, while 90 (34.1%) were female. However, the final sample was only 253 patients who met the inclusion criteria. With regard to Ct values, the study population was divided into the following three groups: Group 1 with Ct values of 9-20 (n = 87; 34.4%), group 2 with Ct values of 21-30 (n = 122; 47.8%), and group 3 with Ct values of 31-42 (n = 44; 17.4%). Conclusions We found that the proportion of male patients infected with COVID-19 was higher compared to females. In addition, the highest incidence was among patients in the age group of 51-70 years. The ferritin and alanine transaminase levels were highest in the initial stage of the infection (group 1) and decreased at the recovery stage. However, neutrophil, lymphocyte, alkaline phosphatase, and C-reactive protein showed an increasing trend from high viral load groups to low viral load groups. The values of the rest of the parameters, such as albumin, total bilirubin, lactate dehydrogenase, and D-dimer, were slightly higher in the initial stage of the infection but the decreasing trend was low; therefore, they were not considered helpful in predicting the disease severity reflected by their Ct value in the three different groups.

摘要

背景 在疫情期间,快速识别新型冠状病毒肺炎(COVID-19)对于患者的治疗和管理至关重要。因此,利用实验室参数对该疾病进行早期诊断有助于对感染患者进行快速管理。本研究旨在调查病毒载量与血液学和生化参数之间的相关性。这最终将有助于医生更好地了解这种新型病毒的动态,并有助于患者的管理。

方法学 阿曼布赖米医院检验科采用口咽拭子和鼻咽拭子,通过逆转录聚合酶链反应(RT-PCR)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进行实验室确诊。收集2020年7月至2021年1月的阳性病例纳入本研究。

结果 在本研究中,最初纳入264例确诊阳性患者,并根据PCR获得的循环阈值(Ct)值分为三组。在总共264例患者中,174例(65.9%)为男性,90例(34.1%)为女性。然而,最终样本仅为253例符合纳入标准的患者。关于Ct值,研究人群分为以下三组:第1组Ct值为9 - 20(n = 87;34.4%),第2组Ct值为21 - 30(n = 122;47.8%),第3组Ct值为31 - 42(n = 44;17.4%)。

结论 我们发现,感染COVID-19的男性患者比例高于女性。此外,发病率最高的是年龄在51 - 70岁的患者。铁蛋白和丙氨酸转氨酶水平在感染初期(第1组)最高,在恢复阶段下降。然而,中性粒细胞、淋巴细胞、碱性磷酸酶和C反应蛋白从高病毒载量组到低病毒载量组呈上升趋势。其余参数,如白蛋白总胆红素、乳酸脱氢酶和D-二聚体的值在感染初期略高,但下降趋势较低;因此,它们在预测由三个不同组的Ct值反映的疾病严重程度方面没有帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/ea596426641b/cureus-0015-00000035228-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/22d0ea15c0a7/cureus-0015-00000035228-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/6ce5b3b0fba6/cureus-0015-00000035228-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/6091bfc3cdd8/cureus-0015-00000035228-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/ea596426641b/cureus-0015-00000035228-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/22d0ea15c0a7/cureus-0015-00000035228-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/6ce5b3b0fba6/cureus-0015-00000035228-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/6091bfc3cdd8/cureus-0015-00000035228-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f39/10032618/ea596426641b/cureus-0015-00000035228-i04.jpg

相似文献

1
Correlation of Viral Load With the Biochemical and Hematological Profiles of COVID-19 Patients in Al Buraimi Hospital, Sultanate of Oman: A Cross-Sectional Study.阿曼苏丹国布赖米医院新冠肺炎患者病毒载量与生化和血液学指标的相关性:一项横断面研究
Cureus. 2023 Feb 20;15(2):e35228. doi: 10.7759/cureus.35228. eCollection 2023 Feb.
2
Correlation of Viral Load With the Clinical and Biochemical Profiles of COVID-19 Patients.病毒载量与COVID-19患者临床和生化特征的相关性
Cureus. 2021 Jul 27;13(7):e16655. doi: 10.7759/cureus.16655. eCollection 2021 Jul.
3
Relationship of Viral Load with the Laboratory Markers and Prognosis in COVID-19 Patients.新型冠状病毒肺炎患者病毒载量与实验室指标及预后的关系
Med J Islam Repub Iran. 2023 Jun 14;37:67. doi: 10.47176/mjiri.37.67. eCollection 2023.
4
[Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].[用于呼吸道样本中检测严重急性呼吸综合征冠状病毒2的快速抗原检测试剂盒与聚合酶链反应的评估]
Mikrobiyol Bul. 2022 Apr;56(2):263-273. doi: 10.5578/mb.20229806.
5
Association of COVID-19 Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Cycle Threshold Value With Surrogate Markers of Disease Severity.新型冠状病毒肺炎实时逆转录聚合酶链反应(RT-PCR)循环阈值与疾病严重程度替代标志物的关联
Cureus. 2022 Nov 2;14(11):e31034. doi: 10.7759/cureus.31034. eCollection 2022 Nov.
6
Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.随机临床试验比较伊维菌素与安慰剂对秘鲁早期 COVID-19 患者鼻咽 PCR 转阴的疗效(SAINT-Peru):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 9;22(1):262. doi: 10.1186/s13063-021-05236-2.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic.严重急性呼吸综合征冠状病毒 2 型感染:初始病毒载量(iVL)可预测疾病严重程度/结局,住院患者 iVL 的下降趋势与大流行的减缓相对应。
PLoS One. 2021 Sep 16;16(9):e0255981. doi: 10.1371/journal.pone.0255981. eCollection 2021.
9
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
10
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.

本文引用的文献

1
Virus infection induced pulmonary fibrosis.病毒感染导致的肺纤维化。
J Transl Med. 2021 Dec 7;19(1):496. doi: 10.1186/s12967-021-03159-9.
2
Severity of SARS-CoV-2 infection and albumin levels recorded at the first emergency department evaluation: a multicentre retrospective observational study.首次急诊科评估时记录的严重急性呼吸综合征冠状病毒 2 感染和白蛋白水平:一项多中心回顾性观察研究。
Emerg Med J. 2022 Jan;39(1):63-69. doi: 10.1136/emermed-2020-210081. Epub 2021 Sep 21.
3
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19.
新冠病毒动力学及实时逆转录聚合酶链反应(RT-PCR)Ct值与COVID-19疾病严重程度的相关性
Diagnostics (Basel). 2021 Jun 15;11(6):1091. doi: 10.3390/diagnostics11061091.
4
Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.动态肝功能变化及其与 COVID-19 患者疾病严重程度和死亡率的相关性:一项回顾性队列研究。
Clin Interv Aging. 2021 Apr 21;16:675-685. doi: 10.2147/CIA.S303629. eCollection 2021.
5
Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.新型冠状病毒肺炎患者疾病严重程度与炎症相关参数的相关性分析:一项回顾性研究。
BMC Infect Dis. 2020 Dec 21;20(1):963. doi: 10.1186/s12879-020-05681-5.
6
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.严重 COVID-19、儿童多系统炎症综合征和川崎病:免疫机制、临床表现和治疗。
Rheumatol Int. 2021 Jan;41(1):19-32. doi: 10.1007/s00296-020-04749-4. Epub 2020 Nov 21.
7
Laboratory Biomarkers in the Management of Patients With COVID-19.新型冠状病毒肺炎患者管理中的实验室生物标志物
Am J Clin Pathol. 2021 Feb 11;155(3):333-342. doi: 10.1093/ajcp/aqaa205.
8
Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19.日本重症 COVID-19 患者肝功能障碍与肝脏 CT 值降低相关的意义。
J Gastroenterol. 2020 Nov;55(11):1098-1106. doi: 10.1007/s00535-020-01717-4. Epub 2020 Aug 9.
9
Relationship of chest CT score with clinical characteristics of 108 patients hospitalized with COVID-19 in Wuhan, China.中国武汉 108 例 COVID-19 住院患者的胸部 CT 评分与临床特征的关系。
Respir Res. 2020 Jul 14;21(1):180. doi: 10.1186/s12931-020-01440-x.
10
Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)患者初始病毒载量与结局和症状的关系。
Am J Pathol. 2020 Sep;190(9):1881-1887. doi: 10.1016/j.ajpath.2020.07.001. Epub 2020 Jul 3.